| Flow-injection analysis for meloxicam based on tris(2,2'-bipyridine)ruthenium(II)-Ce(IV) chemiluminescent system. | Luminescence | 2009 Jul-Aug | 19294660 |
| Systematic review of the management of canine osteoarthritis. | Vet Rec | 2009 Apr 4 | 19346540 |
| Diclofenac toxicity in Gyps vulture is associated with decreased uric acid excretion and not renal portal vasoconstriction. | Comp Biochem Physiol C Toxicol Pharmacol | 2009 Apr | 18727958 |
| Pharmacokinetics and pharmacodynamics of meloxicam in piglets. | J Vet Pharmacol Ther | 2008 Jun | 18471146 |
| Long-term safety, efficacy and palatability of oral meloxicam at 0.01-0.03 mg/kg for treatment of osteoarthritic pain in cats. | J Feline Med Surg | 2008 Jul | 18440263 |
| Evaluation of Enterococcus mundtii ST4SA and Lactobacillus plantarum 423 asprobiotics by using a gastro-intestinal model with infant milk formulations assubstrate. | Int J Food Microbiol | 2008 Dec 10 | 18963159 |
| The pharmacokinetics of meloxicam in vultures. | J Vet Pharmacol Ther | 2008 Apr | 18307504 |
| Differential effects of selective cyclooxygenase (COX)-1 and COX-2 inhibitors on anorexic response and prostaglandin generation in various tissues induced by zymosan. | Biol Pharm Bull | 2006 Jul | 16819161 |
| Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. | Drug Saf | 2005 | 16180941 |
| Multi-residue liquid chromatography/tandem mass spectrometry method for thedetection of non-steroidal anti-inflammatory drugs in bovine muscle: optimisationof ion trap parameters. | Rapid Commun Mass Spectrom | 2004 | 15508142 |